Compare Pfizer Inc (PFE) vs Upwork Inc (UPWK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Pfizer Inc vs Upwork Inc — how do they compare? Pfizer Inc trades at $27.95 (market cap $158.56B), while Upwork Inc trades at $8.63 (market cap $1.07B). The key difference: Pfizer Inc is far larger — about 148.2× Upwork Inc's market cap, and Pfizer Inc pays a 6.18% dividend while Upwork Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Pfizer Inc for 158 Days and Upwork Inc for 38 Days on average.
| PFE | UPWK | |
|---|---|---|
Market Cap | $158.56B | $1.07B |
Volume | 44,138,282 | 2,574,130 |
Sector | Health | Industrials |
52-Week High | $29.02 | $22.11 |
52-Week Low | $23.67 | $7.84 |
Typical Hold Time | 158 Days | 38 Days |
Enterprise Value | $210.06B | $833.01M |
Dividend Yield | 6.18% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Pfizer (PFE) trades at $28.00, up 1.87% on the day, with a bullish technical signal from moving averages. The company reported revenue of $62.58 billion in 2025 with a net income margin of 6.8%, and has beaten EPS estimates for the last three quarters. Recent news highlights Pfizer's focus on its obesity and oncology pipeline as key growth drivers in 2026.
The stock presents a value opportunity with a consensus price target of $29.17, but faces risks from patent expirations and projected earnings decline. Investor sentiment is mixed, with analysts largely neutral, emphasizing the stock's defensive cash flow and dividend yield amid ongoing business transformation.
Upwork trades at $8.40, up 0.48% on the day, with a bearish technical signal and neutral oscillators. The company reported Q2 2026 EPS of $0.41, beating expectations, but revenue guidance disappointed, causing a recent sell-off. Financials show strong gross margins of 77.21% and a P/E of 10.99, indicating potential undervaluation. Recent news includes insider selling and a securities fraud investigation, adding to investor caution.
The outlook is mixed: solid profitability and low valuation offer upside, but AI disruption risks and weak guidance pose challenges. Analysts are split with a $9.64 price target, suggesting moderate upside from current levels if execution improves and sentiment recovers.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Pfizer Inc
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →About Upwork Inc
Upwork Inc is a United States-based company that operates an online marketplace that enables businesses to find and work with highly-skilled independent professionals. The develops platform for hiring and freelancing purposes. Its products offering include Upwork Basic, Upwork Plus, Upwork Business, Upwork Enterprise, and Upwork Payroll. The business generates revenue from Talent and Clients across the USA, India, the Philippines and the rest of the world. Substantial income is derived from providing services to Clients.
Read more on UPWK →
